Soleno Therapeutics Inc financial data

Symbol
SLNO on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
100 Marine Parkway, Suite 400, Redwood City, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Capnia, Inc. (to 5/11/2017)
Latest financial report
10-K - Q4 2024 - Feb 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.72K % +286%
Debt-to-equity 17.9 % -64.7%
Return On Equity -75.3 % +5.45%
Return On Assets -63.9 % -20.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 45.9M shares +41.3%
Common Stock, Shares, Outstanding 45.7M shares +44.3%
Entity Public Float 1.4B USD +4130%
Common Stock, Value, Issued 46K USD +43.8%
Weighted Average Number of Shares Outstanding, Basic 40.2M shares +144%
Weighted Average Number of Shares Outstanding, Diluted 40.2M shares +144%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 78.6M USD +212%
General and Administrative Expense 106M USD +685%
Operating Income (Loss) -188M USD -353%
Nonoperating Income (Expense) 11.8M USD +393%
Net Income (Loss) Attributable to Parent -176M USD -351%
Earnings Per Share, Basic -4.38 USD/shares -85.6%
Earnings Per Share, Diluted -4.38 USD/shares -85.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 87.9M USD -48.2%
Marketable Securities, Current 204M USD
Assets, Current 294M USD +71.5%
Property, Plant and Equipment, Net 186K USD +1450%
Operating Lease, Right-of-Use Asset 2.8M USD +587%
Intangible Assets, Net (Excluding Goodwill) 6.81M USD -22.2%
Other Assets, Noncurrent 83K USD -49.7%
Assets 331M USD +83.2%
Accounts Payable, Current 8.88M USD +182%
Employee-related Liabilities, Current 4.78M USD +52.3%
Liabilities, Current 18.7M USD +62.9%
Operating Lease, Liability, Noncurrent 2.47M USD +1802%
Other Liabilities, Noncurrent 21K USD
Liabilities 85.9M USD +270%
Accumulated Other Comprehensive Income (Loss), Net of Tax 361K USD
Retained Earnings (Accumulated Deficit) -452M USD -63.6%
Stockholders' Equity Attributable to Parent 245M USD +55.6%
Liabilities and Equity 331M USD +83.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.5M USD -86.2%
Net Cash Provided by (Used in) Financing Activities 938K USD
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 45.7M shares +44.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -127M USD -1785%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 87.9M USD -48.2%
Deferred Tax Assets, Valuation Allowance 83.5M USD +26.6%
Deferred Tax Assets, Gross 85.5M USD +26%
Operating Lease, Liability 3M USD +644%
Payments to Acquire Property, Plant, and Equipment 11K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -175M USD -350%
Lessee, Operating Lease, Liability, to be Paid 3.71M USD +763%
Property, Plant and Equipment, Gross 256K USD +153%
Operating Lease, Liability, Current 526K USD +92.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 751K USD +425%
Lessee, Operating Lease, Liability, to be Paid, Year One 494K USD +72.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 715K USD +2548%
Lessee, Operating Lease, Liability, to be Paid, Year Three 861K USD
Deferred Tax Assets, Operating Loss Carryforwards 44.3M USD -13.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 6.37M USD +117%
Lessee, Operating Lease, Liability, to be Paid, Year Four 942K USD
Operating Lease, Payments 64K USD -46.2%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 83.5M USD +26.6%
Share-based Payment Arrangement, Expense 100M USD +1581%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%